查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1703482

夫西地酸市场－全球产业规模、份额、趋势、机会和预测，按销售管道（直接、间接）、最终用途（脓疱病、蜂窝性组织炎、割伤和伤口、眼部感染、其他）、按地区和竞争情况划分，2020 年至 2030 年预测

Fusidic Acid Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Sales Channel (Direct, Indirect), By End Use (Impetigo, Cellulitis, Cuts & Wounds, Eye Infection, Others), By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

2024 年全球夫西地酸市值为 2,971 万美元，预计到 2030 年将达到 4,212 万美元，预测期内的年复合成长率(CAGR) 为 2.02%。夫西地酸在治疗细菌感染（尤其是影响皮肤和软组织的感染）中的应用日益增多，推动了市场稳定成长。

市场概览
预测期 2026-2030
2024年市场规模 2971万美元
2030年市场规模 4212万美元
2025-2030 年复合年增长率 2.02%
成长最快的领域 直接的
最大的市场 亚太

夫西地酸是一种强效抗生素，通常有外用和口服两种剂型，主要用于治疗金黄色葡萄球菌引起的感染，包括耐甲氧西林菌株 (MRSA)，这种感染在医院和社区环境中日益受到关注。随着抗生素抗药性成为日益严重的全球性问题，对夫西地酸等有效替代品的需求日益增长。

这种抗生素广泛用于药物和皮肤病製剂，特别用于治疗脓疱病、毛囊炎和蜂窝性组织炎等皮肤病。这些感染的发生率不断上升，加上全球人口老化，正在刺激各地区对夫西地酸的需求。此外，人们对抗生素抗药性的认识不断提高，也增强了人们对以夫西地酸为基础的治疗的兴趣。全球市场的特点是品牌产品和仿製药混合，仿製药由于其价格实惠和更广泛的可用性而越来越受到关注。

关键市场驱动因素

全球医疗保健产业的扩张

主要市场挑战

安全问题和不良反应

主要市场趋势

眼部感染发生率上升

目录

第 1 章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：COVID-19 对全球夫西地酸市场的影响

第五章：全球夫西地酸市场展望

  • 市场规模和预测
    • 按价值
  • 市场占有率和预测
    • 按销售管道（直接、间接）
    • 依最终用途（脓疱病、蜂窝性组织炎、割伤和伤口、眼部感染、其他）
    • 按地区
    • 按公司分类（2024）
  • 市场地图

第六章：北美夫西地酸市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 北美：国家分析
    • 美国
    • 墨西哥
    • 加拿大

第七章：欧洲夫西地酸市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 欧洲：国家分析
    • 法国
    • 德国
    • 英国
    • 义大利
    • 西班牙

第八章：亚太地区夫西地酸市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 亚太地区：国家分析
    • 中国
    • 印度
    • 韩国
    • 日本
    • 澳洲

第九章：南美夫西地酸市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 南美洲：国家分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第十章：中东与非洲夫西地酸市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • MEA：国家分析
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋

第 11 章：市场动态

  • 驱动程式
  • 挑战

第 12 章：市场趋势与发展

  • 合併与收购（如有）
  • 产品发布（如有）
  • 最新动态

第 13 章：全球夫西地酸市场：SWOT 分析

第 14 章：波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的力量
  • 顾客的力量
  • 替代产品的威胁

第 15 章：竞争格局

  • Ercros SA
  • Emote Life sciences LLP
  • Kaniwa Bioscience Pvt. Ltd
  • Concord Biotech Limited
  • Fleming Laboratories Ltd
  • Sterling Biotech Ltd
  • Oliver Pharmaceuticals
  • Apex Healthcare Ltd
  • Horster Life Sciences Pvt. Ltd.
  • Celaxis Bioscience Pvt Ltd

第 16 章：策略建议

第17章调查会社について・免责事项

简介目录
Product Code: 28286

Global Fusidic Acid Market was valued at USD 29.71 million in 2024 and is projected to reach USD 42.12 million by 2030, growing at a compound annual growth rate (CAGR) of 2.02% over the forecast period. Market growth is being steadily driven by the increasing application of fusidic acid in treating bacterial infections, particularly those affecting the skin and soft tissues.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 29.71 Million
Market Size 2030USD 42.12 Million
CAGR 2025-20302.02%
Fastest Growing SegmentDirect
Largest MarketAsia-Pacific

Fusidic acid is a potent antibiotic commonly available in both topical and oral formulations, primarily used to treat infections caused by Staphylococcus aureus, including methicillin-resistant strains (MRSA), which are a growing concern in both hospital and community settings. As antibiotic resistance becomes an escalating global issue, the need for effective alternatives such as fusidic acid is gaining momentum.

This antibiotic is widely used in pharmaceutical and dermatological formulations, with a particular focus on treating skin conditions like impetigo, folliculitis, and cellulitis. The rising incidence of these infections, coupled with an aging global population, is fueling demand for fusidic acid across various geographies. Additionally, heightened awareness surrounding antibiotic resistance has intensified interest in fusidic acid-based treatments. The global market is characterized by a mix of branded and generic products, with generic formulations increasingly gaining traction due to their affordability and broader availability.

Key Market Drivers

Expansion of the Global Healthcare Industry

The ongoing growth of the global healthcare sector is a significant catalyst for the fusidic acid market. Worldwide healthcare sales are projected to surpass USD 4 trillion annually, with pharmaceuticals and biotechnology representing the most substantial segments-generating close to USD 850 billion-followed by medical technology and diagnostics at over USD 400 billion.

Fusidic acid is recognized as a valuable therapeutic solution for a range of bacterial infections, including skin, eye, and soft tissue infections. As the demand for targeted and effective treatments rises, driven by the increasing incidence of bacterial infections and improvements in healthcare infrastructure and accessibility, the market for fusidic acid continues to expand.

Key Market Challenges

Safety Concerns and Adverse Effects

One of the primary concerns surrounding the use of fusidic acid is its potential hepatotoxicity. Prolonged use or high dosages can lead to liver complications such as hepatitis or jaundice-particularly in patients with existing liver conditions, thereby increasing the risk of adverse reactions. As a result, patients undergoing treatment with fusidic acid often require regular liver function monitoring to mitigate risks.

These safety considerations limit the duration for which fusidic acid can be prescribed, posing challenges in cases that demand long-term antibiotic therapy. In addition, while topical formulations are widely used for skin infections, they can cause local side effects such as irritation, redness, itching, or rashes-sometimes resulting in treatment discontinuation among sensitive individuals.

Although rare, allergic reactions-including severe responses such as anaphylaxis-can occur, especially in immunocompromised populations. These potential risks may hinder wider market adoption. To address this, manufacturers must implement clear labeling, patient education, and effective monitoring practices to ensure safe and informed usage.

Key Market Trends

Rising Incidence of Eye Infections

A notable trend propelling the global fusidic acid market is the increasing prevalence of bacterial eye infections. According to the World Health Organization (WHO), trachoma alone is responsible for approximately 1.9 million cases of blindness or visual impairment across 42 countries, representing 1.4% of global blindness. The economic burden associated with this condition is estimated between USD 2.9 billion and USD 5.3 billion annually.

Bacterial eye infections caused by pathogens such as Staphylococcus aureus and Streptococcus pneumoniae are on the rise due to several factors, including environmental pollution, rapid urbanization, and lifestyle-related changes. Fusidic acid, known for its efficacy in treating localized bacterial infections, has emerged as a key solution for conditions such as bacterial conjunctivitis, blepharitis, and keratitis.

This upward trend is further supported by increasing exposure to environmental irritants, allergens, and extended screen time, all of which contribute to eye dryness and a higher risk of infection. Additionally, the growing global use of contact lenses-particularly in urban populations-has led to a rise in bacterial eye infections linked to poor hygiene and prolonged wear. These factors are driving the demand for fusidic acid-based ophthalmic treatments, reinforcing its role in the evolving landscape of infectious disease management.

Key Market Players

  • Ercros S.A
  • Emote Life sciences LLP
  • Kaniwa Bioscience Pvt. Ltd
  • Concord Biotech Limited
  • Fleming Laboratories Ltd
  • Sterling Biotech Ltd
  • Oliver Pharmaceuticals
  • Apex Healthcare Ltd
  • Horster Life Sciences Pvt. Ltd.
  • Celaxis Bioscience Pvt Ltd

Report Scope

In this report, the Global Fusidic Acid Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Fusidic Acid Market, By Sales Channel:

  • Direct
  • Indirect

Fusidic Acid Market, By End Use:

  • Impetigo
  • Cellulitis
  • Cuts & Wounds
  • Eye Infection
  • Others

Fusidic Acid Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Fusidic Acid Market.

Available Customizations:

Global Fusidic Acid Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, and Trends

4. Impact of COVID-19 on Global Fusidic Acid Market

5. Global Fusidic Acid Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Sales Channel (Direct, Indirect)
    • 5.2.2. By End Use (Impetigo, Cellulitis, Cuts & Wounds, Eye Infection, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Market Map

6. North America Fusidic Acid Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Sales Channel
    • 6.2.2. By End Use
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Fusidic Acid Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Sales Channel
        • 6.3.1.2.2. By End Use
    • 6.3.2. Mexico Fusidic Acid Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Sales Channel
        • 6.3.2.2.2. By End Use
    • 6.3.3. Canada Fusidic Acid Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Sales Channel
        • 6.3.3.2.2. By End Use

7. Europe Fusidic Acid Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Sales Channel
    • 7.2.2. By End Use
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Fusidic Acid Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Sales Channel
        • 7.3.1.2.2. By End Use
    • 7.3.2. Germany Fusidic Acid Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Sales Channel
        • 7.3.2.2.2. By End Use
    • 7.3.3. United Kingdom Fusidic Acid Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Sales Channel
        • 7.3.3.2.2. By End Use
    • 7.3.4. Italy Fusidic Acid Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Sales Channel
        • 7.3.4.2.2. By End Use
    • 7.3.5. Spain Fusidic Acid Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Sales Channel
        • 7.3.5.2.2. By End Use

8. Asia Pacific Fusidic Acid Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Sales Channel
    • 8.2.2. By End Use
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Fusidic Acid Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Sales Channel
        • 8.3.1.2.2. By End Use
    • 8.3.2. India Fusidic Acid Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Sales Channel
        • 8.3.2.2.2. By End Use
    • 8.3.3. South Korea Fusidic Acid Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Sales Channel
        • 8.3.3.2.2. By End Use
    • 8.3.4. Japan Fusidic Acid Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Sales Channel
        • 8.3.4.2.2. By End Use
    • 8.3.5. Australia Fusidic Acid Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Sales Channel
        • 8.3.5.2.2. By End Use

9. South America Fusidic Acid Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Sales Channel
    • 9.2.2. By End Use
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Fusidic Acid Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Sales Channel
        • 9.3.1.2.2. By End Use
    • 9.3.2. Argentina Fusidic Acid Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Sales Channel
        • 9.3.2.2.2. By End Use
    • 9.3.3. Colombia Fusidic Acid Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Sales Channel
        • 9.3.3.2.2. By End Use

10. Middle East and Africa Fusidic Acid Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Sales Channel
    • 10.2.2. By End Use
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Fusidic Acid Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Sales Channel
        • 10.3.1.2.2. By End Use
    • 10.3.2. Saudi Arabia Fusidic Acid Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Sales Channel
        • 10.3.2.2.2. By End Use
    • 10.3.3. UAE Fusidic Acid Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Sales Channel
        • 10.3.3.2.2. By End Use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Fusidic Acid Market: SWOT Analysis

14. Porters Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Ercros S.A
    • 15.1.1. Business Overview
    • 15.1.2. Company Snapshot
    • 15.1.3. Products & Services
    • 15.1.4. Financials (As Reported)
    • 15.1.5. Recent Developments
    • 15.1.6. Key Personnel Details
    • 15.1.7. SWOT Analysis
  • 15.2. Emote Life sciences LLP
  • 15.3. Kaniwa Bioscience Pvt. Ltd
  • 15.4. Concord Biotech Limited
  • 15.5. Fleming Laboratories Ltd
  • 15.6. Sterling Biotech Ltd
  • 15.7. Oliver Pharmaceuticals
  • 15.8. Apex Healthcare Ltd
  • 15.9. Horster Life Sciences Pvt. Ltd.
  • 15.10. Celaxis Bioscience Pvt Ltd

16. Strategic Recommendations

17. About Us & Disclaimer